Becton, Dickinson and Company Net Debt/EBITDA

Net Debt/EBITDA of BDX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending September 30, 2022 was 17.5 (a 37.91% increase compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA increased by 56.35%
  • Annual Net Debt/EBITDA for 2022 was 3.33 (a -2.74% decrease from previous year)
  • Annual Net Debt/EBITDA for 2021 was 3.42 (a -31.41% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was 4.99 (a 6.65% increase from previous year)
Visit stockrow.com/BDX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Becton, Dickinson and Company

Most recent Net Debt/EBITDAof BDX including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Becton, Dickinson and Company

Becton, Dickinson and Company Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 17.5 12.69 12.64 3.33
2021 11.19 23.02 14.05 13.92 3.42
2020 7.99 76.65 17.74 20.78 4.99
2019 18.32 26.26 14.51 24.0 4.68
2018 11.57 15.45 17.45 28.59 5.81
2017 39.49 5.75 84.71 11.57 1.79
2016 7.24 23.36 10.81 11.87 3.79
2015 14.4 16.15 22.13 23.2 5.01
2014 2.37 1.85 1.92 2.23 0.47
2013 2.41 5.27 2.69 2.59 0.64
2012 2.4 3.06 2.75 3.62 0.76

Business Profile of Becton, Dickinson and Company

Sector: Healthcare
Industry: Medical Instruments & Supplies